A Novel Quantum Dots-Based Fluorescent Sensor for Determination of the Anticancer Dacomitinib: Application to Dosage Forms

One of the most promising drugs recently approved for the treatment of various types of cancer is dacomitinib, which belongs to the tyrosine kinase inhibitor class. The US Food and Drugs Administration (FDA) has recently approved dacomitinib as a first-line treatment for patients suffering from non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Alossaimi, Manal A., Elmansi, Heba, Alajaji, Mai, Altharawi, Ali, Altamimi, Abdulmalik S. A., Magdy, Galal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005270/
https://www.ncbi.nlm.nih.gov/pubmed/36903599
http://dx.doi.org/10.3390/molecules28052351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005270/
https://www.ncbi.nlm.nih.gov/pubmed/36903599
http://dx.doi.org/10.3390/molecules28052351

Ejemplares similares